Use of glaucocalyxin X in preparing anti-cancer medicine

An anti-cancer drug, the technology of Indigo calyx, which is applied in the field of medicine, can solve the problems such as the lack of anti-cancer activity of Indigo calyx X

Inactive Publication Date: 2009-06-17
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] So far there is no report about the anticancer activity of calyxin X

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of glaucocalyxin X in preparing anti-cancer medicine
  • Use of glaucocalyxin X in preparing anti-cancer medicine
  • Use of glaucocalyxin X in preparing anti-cancer medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0009] The present invention will be described in detail below through in vitro anti-tumor experiments.

[0010] In Vitro Antitumor Activity Test of Cerulein X

[0011] 1. Experimental drug:

[0012] The blue calyx X is isolated from the blue calyx, and the preparation method is detailed in [Zhao BaoXiang (xiang Zhaobao), Hai Sheng Chen (Chen Haisheng), et al.Two new diterpenoids from Rabdosia japonica var. glaucocalyx, Chinese Chemical Letter2008; 19:852-854].

[0013] Control drug: doxycycline (DOX), Shijiazhuang Ruitian Biochemical Co., Ltd.

[0014] 2. Cell line: provided by the Pharmacology Laboratory of Shanghai Institute of Pharmaceutical Industry

[0015] ①A549 (human lung cancer cells); ②LOVO (human intestinal cancer cells); ③6T-CEM (human T-cell leukemia cells); ④HL-60 (human leukemia cells)

[0016] 3. Culture medium: RPMI1640+15%NBS+double antibody

[0017] 4 Other materials

[0018] Fully automatic microplate reader: Model: (WellscanMK-2) Manufacturer: Labsy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to technical field of medicine, and relates to the use of diterperoid compound glaucocalyxin X in isodon japonica (Burm.f) Hara var.glaucocalyx (Maxim.) Hara in preparing anti-cancer medicine. The invention adopts an MTT method for executing cytotoxicity experiment. The result shows that the glaucocalyxin X equally has remarkable cytotoxicity and therefore can be used for preparing anti-cancer medicine. The invention provides a new source for preparing the anti-cancer medicine.

Description

technical field [0001] The invention relates to the technical field of medicines, and relates to the use of indigo-X in the preparation of anticancer drugs. Background technique [0002] Glaucocalyxin X (Glaucocalyxin X) is isolated from the whole plant of Glaucocalyx (Rabdosia japonica (Burm.f.) Hara var. glaucocalyx (Maxim.) Hara) by the present inventors. The obtained new compound [Zhao Bao Xiang (xiang Zhaobao), Hai Sheng Chen (陈海生), et al.Two new diterpenoids from Rabdosiajaponica var. glaucocalyx, Chinese Chemical Letter 2008; 19:852-854]. [0003] The chemical structure of Cerulein X is as follows: [0004] [0005] So far, there is no report about the anticancer activity of calyxin X. Contents of the invention [0006] The invention provides an application of the calyxin for the preparation of anticancer drugs. [0007] The present invention adopts MTT method, with A549 (human lung cancer cells), LOVO (human intestinal cancer cells), 6T-CEM (human T-cell leuk...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/357A61P35/00
Inventor 陈海生项昭保刘建国金永生赵卫权
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products